institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

Isolated Gut Microbe Drives Stronger Responses to Cancer Therapy

JAPAN, JUL 16 – The newly discovered gut bacterium YB328 activates immune cells to improve cancer immunotherapy, which currently benefits only about 20% of patients long term, researchers said.

Summary by Medical Xpress
The National Cancer Center Research Institute in Tokyo reports that a newly isolated gut bacterium, designated Hominenteromicrobium strain YB328, mobilizes specialized dendritic cells to strengthen the impact of PD-1 blockade immunotherapy across several tumor types.

8 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources lean Left, 50% of the sources are Center
50% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Mainichi Shimbun broke the news in Chiyoda, Japan on Tuesday, July 15, 2025.
Sources are mostly out of (0)